ProfessorPaul Freemont
Chair in Protein Crystallography
Department of Infectious Disease - Faculty of Medicine
Orcid identifier0000-0002-5658-8486 (opens in a new tab)
- Chair in Protein CrystallographyDepartment of Infectious Disease - Faculty of Medicine
- 020 7594 5327 (Work)
- 259, Sir Alexander Fleming Building, South Kensington Campus, United Kingdom
RESEARCH
My early research interests focused on understanding molecular mechanisms of important biological systems using interdisciplinary structural biology approaches. I was lucky to have been at the Imperial Cancer Research Fund in my early career where many new fundamental biological discoveries were made and one of my contributions was the identification, characterisation and naming of the RING finer domain, the fourth most commonest domain found in eukaryotes and key for mediating protein ubiquitylation of proteins.
I had a long standing interest in RING-finger proteins and associated pathways including PML and RING-1 and also the role of p97/VAT, a AAA ATPase machine which is involved in many functional pathways through interacting with a plethora of adaptor proteins including p47. The understanding of how cells maintain protein homeostasis by using protein tagging and degradation, protein complex disassembly and recycling is hugely important in understanding many human disease states including cancer and neurodegenerative diseases.
Over the last several years my research interests have focused on synthetic biology. By applying engineering design approaches to construct new biological systems at the genetic level, the opportunity to both explore complex biological systems and apply these to different applications is compelling. My main interests focus on cell free systems and the ability to carry out transcription and translation assays for both prototyping biological designs but also for discovery - for example natural products and new enzyme and the construction of synthetic cells. Another major interest I have is in biofoundries and their role in automating many of the molecular biology tools used for biological design as well as establishing workflows for the synthetic biology design cycle. I was fortunate to be a co-founder and founding chair of the Global Biofoundry Alliance, an organisation of 36 public-funded facilities worldwide with the opportunity for open source developments, sharing expertise and skills and collaborating on globally relevant problems.
Synthetic biology provides an extraordinary tool kit to both explore and construct novel biological systems which can be applied to solve some of the existential challenges we face which includes climate alteration and repair, food security, clean water and infectious disease to name but a few.
I had a long standing interest in RING-finger proteins and associated pathways including PML and RING-1 and also the role of p97/VAT, a AAA ATPase machine which is involved in many functional pathways through interacting with a plethora of adaptor proteins including p47. The understanding of how cells maintain protein homeostasis by using protein tagging and degradation, protein complex disassembly and recycling is hugely important in understanding many human disease states including cancer and neurodegenerative diseases.
Over the last several years my research interests have focused on synthetic biology. By applying engineering design approaches to construct new biological systems at the genetic level, the opportunity to both explore complex biological systems and apply these to different applications is compelling. My main interests focus on cell free systems and the ability to carry out transcription and translation assays for both prototyping biological designs but also for discovery - for example natural products and new enzyme and the construction of synthetic cells. Another major interest I have is in biofoundries and their role in automating many of the molecular biology tools used for biological design as well as establishing workflows for the synthetic biology design cycle. I was fortunate to be a co-founder and founding chair of the Global Biofoundry Alliance, an organisation of 36 public-funded facilities worldwide with the opportunity for open source developments, sharing expertise and skills and collaborating on globally relevant problems.
Synthetic biology provides an extraordinary tool kit to both explore and construct novel biological systems which can be applied to solve some of the existential challenges we face which includes climate alteration and repair, food security, clean water and infectious disease to name but a few.
GRANTS
- STANDARD - RESPONSEAn Accumulation Rulebook & Vulnerability Atlas for Klebsiella spp.Wellcome Trust22 Mar 2026 - 21 Mar 2029
- STANDARD - CALLGSK-Fleming Initiative, Grand Challenge 2Glaxosmithkline Research and Development Ltd11 Nov 2025 - 10 Nov 2028
- STANDARD - CALLProof-of-concept fundingEngineering & Physical Sciences Research Council1 Jun 2024 - 31 May 2027
- STANDARD - CALLHuman functional genomics of post-translationally modifying clinical coding variantsMedical Research Council (MRC)14 May 2024 - 13 May 2028
- CENTRE / HUBUKRI Sustainable Microbial Food Mission HubBiotechnology and Biological Sciences Research Council6 May 2024 - 5 May 2029
- CENTRE / HUBUKDRI Care Research & Technology 23-28UK DRI Ltd1 Apr 2023 - 31 Mar 2030
- STANDARD - CALLUnderstanding the need for global metrics in synthetic biologyTechnology Innovation Institute - Sole Proprietors1 Jan 2023 - 31 Mar 2025
- STANDARD - CALLSUPERB: Synbio + Universal Purification of Extract-derived, Right-on-time BiologicsDefense Advanced Research Projects Agency (USA)15 Dec 2022 - 29 Feb 2024
- STANDARD - CALLOMEGA: Outer membrane vesicle engineering and manufacturingEngineering & Physical Science Research Council (EPSRC)1 Oct 2022 - 31 Mar 2026
- STANDARD - CALLFeasibility of implementing an early detection assay for UTIs in care homesImperial College Healthcare NHS Trust- BRC Funding1 Apr 2022 - 30 Nov 2022
- STANDARD - CALLMRC UKRI IAA 22-25Medical Research Council (MRC)1 Apr 2022 - 31 Mar 2027
- STANDARD - CALL21ENGBIO PROJECT ECHO: Modular exosome prototyping & engineeringBiotechnology and Biological Sciences Research Cou21 Jan 2022 - 20 Oct 2022
- GRANTA modern cryo-EM instrument for biological samples at Imperial College LondonWellcome Trust21 Sep 2020 - 20 Sep 2025
- GRANTCommercial opportunities for an automated extracellular vesicle biofoundryBiotechnology and Biological Sciences Research Council (BBSRC)1 Jun 2020 - 30 Sep 2021
- GRANTEquipping the Next Generation of INnovative biological Engineers to develop disease diagnostics for AfricaBiotechnology and Biological Sciences Research Cou1 Apr 2020 - 31 Mar 2022
- GRANTDeveloping Standardized Cell-Free Platforms for Rapid Prototyping of Complex Synthetic Biology Circuits and PathwaysEngineering & Physical Science Research Council (EPSRC)15 Dec 2019 - 13 Jun 2023
- GRANT[Australia] Construction of Synthetic Yeast Chromosomes using BioFoundries in United Kingdom and AustraliaBiotechnology and Biological Sciences Research Council (BBSRC)1 Jul 2019 - 30 Jun 2023
- GRANTUK DRI Care Research & Technology CentreUK DRI Ltd1 May 2019 - 30 Apr 2025
- GRANTEPSRC Impact Acceleration Account 2017-2020Engineering & Physical Science Research Council (E1 Apr 2017 - 31 Mar 2022